PROTAGONIST THERAPEUTICS INC (PTGX) Stock Cash Flow
NASDAQ:PTGX - Nasdaq - US74366E1029 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 56.19M | 275.19M | -78.95M | -127.39M | -125.55M | |||
| Depreciation Amortization | 3.47M | 2.90M | 3.31M | 1.03M | 810.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | N/A | |||
| Change In Working Capital | 245.41M | -122.61M | -19.51M | -7.77M | -3.31M | |||
| Taxes Paid | N/A | 1.53M | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 31.88M | 28.68M | 24.92M | 25.99M | 20.19M | |||
| OPERATING CASH FLOW | 336.94M | 184.15M | -70.24M | -108.14M | -107.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.66M | -1.35M | -609.00K | -800.00K | -1.10M | |||
| Other Investing Activity | -398.30M | -298.13M | -38.65M | 92.26M | -14.76M | |||
| INVESTING CASH FLOW | -399.96M | -299.48M | -39.26M | 91.47M | -15.86M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | N/A | |||
| Stock Issued/Repurchased | 30.58M | 26.45M | 171.25M | 19.00M | 130.11M | |||
| Other Financing Activity | -479.00K | -600.00K | -769.00K | -160.00K | -190.00K | |||
| FINANCING CASH FLOW | 30.10M | 25.85M | 170.48M | 18.84M | 129.92M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | -90.00K | -130.00K | |||
| CHANGE IN CASH | -32.91M | -89.48M | 60.98M | 2.08M | 6.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 336.94M | 184.15M | -70.24M | -108.14M | -107.87M | |||
| Capital Expenditure | -1.66M | -1.35M | -609.00K | -800.00K | -1.10M | |||
| FREE CASH FLOW | 335.29M | 182.80M | -70.84M | -108.94M | -108.97M | |||
All data in USD